Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban
Clinical and Molecular Hepatology
;
: 499-502, 2016.
Article
in English
| WPRIM
| ID: wpr-54507
ABSTRACT
Cirrhosis can occur with the development of portal vein thrombosis (PVT). PVT may aggravate portal hypertension, and it can lead to hepatic decompensation. The international guideline recommends for anticoagulation treatment to be maintained for at least 3 months in all patients with acute PVT. Low-molecular-weight-heparin and changing to warfarin is the usual anticoagulation treatment. However, warfarin therapy is problematic due to a narrow therapeutic window and the requirement for frequent dose adjustment, which has prompted the development of novel oral anticoagulants for overcoming these problems. We report a 63-year-old female who experienced complete resolution of recurrent acute PVT in liver cirrhosis after treatment with rivaroxaban.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Portal Vein
/
Recurrence
/
Tomography, X-Ray Computed
/
Administration, Oral
/
Venous Thrombosis
/
Factor Xa Inhibitors
/
Rivaroxaban
/
Liver Cirrhosis
Type of study:
Practice guideline
Limits:
Female
/
Humans
Language:
English
Journal:
Clinical and Molecular Hepatology
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS